Paul Hutton
Overview
Explore the profile of Paul Hutton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
727
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hutton P, Kelly J, Taylor C, Williams B, Emsley R, Alexander C, et al.
Pilot Feasibility Stud
. 2023 Aug;
9(1):142.
PMID: 37580805
No abstract available.
2.
Hutton P, Kelly J, Taylor C, Williams B, Emsley R, Alexander C, et al.
Pilot Feasibility Stud
. 2023 Jul;
9(1):117.
PMID: 37422659
Background: A high proportion of patients diagnosed with schizophrenia-spectrum disorders will at some point in their lives be assessed as not having the capacity to make their own decisions about...
3.
Mc Glanaghy E, Jackson J, Morris P, Prentice W, Dougall N, Hutton P
Clin Psychol Psychother
. 2021 Jul;
29(2):579-589.
PMID: 34260130
Measurement of adverse effects of psychological therapy is inconsistent due to ambiguity about the concept. The perspective of people undertaking psychological therapy (that is, experts by experience) has largely been...
4.
Mc Glanaghy E, Turner D, Davis G, Sharpe H, Dougall N, Morris P, et al.
Schizophr Res
. 2021 Feb;
228:447-459.
PMID: 33578368
Background: Evidence for the effectiveness of psychological interventions for schizophrenia/psychosis is growing, however there is no consensus on the psychological intervention most likely to reduce symptoms. Methods: A network meta-analysis...
5.
Cullen M, Huddart R, Joffe J, Gardiner D, Maynard L, Hutton P, et al.
Eur Urol
. 2020 Jan;
77(3):344-351.
PMID: 31901440
Background: Standard management in the UK for high-risk stage 1 nonseminoma germ cell tumours of the testis (NSGCTT) is two cycles of adjuvant bleomycin, etoposide (360 mg/m), and cisplatin (BEP)...
6.
Karatzias T, Murphy P, Cloitre M, Bisson J, Roberts N, Shevlin M, et al.
Psychol Med
. 2019 Mar;
49(11):1761-1775.
PMID: 30857567
Background: The 11th revision to the WHO International Classification of Diseases (ICD-11) identified complex post-traumatic stress disorder (CPTSD) as a new condition. There is a pressing need to identify effective...
7.
Morrison A, Pyle M, Gumley A, Schwannauer M, Turkington D, MacLennan G, et al.
Health Technol Assess
. 2019 Feb;
23(7):1-144.
PMID: 30806619
Background: Clozapine (clozaril, Mylan Products Ltd) is a first-choice treatment for people with schizophrenia who have a poor response to standard antipsychotic medication. However, a significant number of patients who...
8.
Paterson C, Karatzias T, Harper S, Dougall N, Dickson A, Hutton P
Br J Clin Psychol
. 2018 Dec;
58(2):211-230.
PMID: 30506981
Objectives: Acute psychiatric inpatient wards are characterized by minimal provision of therapeutic activities and high readmission rates. Implementation of a comprehensive inpatient psychological intervention service has been recommended to overcome...
9.
Hutton P, Di Rienzo F, Turkington D, Spencer H, Taylor P
Schizophr Bull
. 2018 Nov;
45(1):37-47.
PMID: 30388270
Between 5% and 10% of people with psychosis will die by suicide, a rate which is 20-75 times higher than the general population. This risk is even greater in those...
10.
Murphy P, Bentall R, Freeman D, ORourke S, Hutton P
Lancet Psychiatry
. 2018 Oct;
5(11):913-929.
PMID: 30314852
Background: An influential psychological model of persecutory delusions proposed that they are caused by a bias towards holding others responsible for negative events (an externalising attributional bias), preventing the individual...